We are live on ! Find out more
GI

GAMMA Investing Portfolio holdings

AUM $2.69B
1-Year Est. Return 42.78%
This Fund
S&P 500
This Quarter Est. Return
+4.35%
1 Year Est. Return
+42.78%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$734M
AUM Growth
+$243M
Cap. Flow
+$225M
Cap. Flow %
30.62%
Top 10 Hldgs %
26.45%
Holding
3,583
New
262
Increased
2,226
Reduced
647
Closed
123

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$11.8M
2
MSFT icon
Microsoft
MSFT
+$11.5M
3
NVDA icon
NVIDIA
NVDA
+$9.6M
4
AMZN icon
Amazon
AMZN
+$6.13M
5
LLY icon
Eli Lilly
LLY
+$3.88M

Sector Composition

Rank Sector Weight
1 Technology 25.56%
2 Financials 11.92%
3 Healthcare 9.56%
4 Consumer Discretionary 7.9%
5 Industrials 7.5%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NMRA icon
3001
Neumora Therapeutics
NMRA
$302M
$157 ﹤0.01%
16
+7
+78% +$72
HIPO icon
3002
Hippo Holdings
HIPO
$861M
$155 ﹤0.01%
+9
New +$171
TCX icon
3003
Tucows
TCX
$175M
$155 ﹤0.01%
8
-40
-83% -$769
CIM
3004
Chimera Investment
CIM
$1B
$154 ﹤0.01%
+12
New +$152
BFST icon
3005
Business First Bancshares
BFST
$1.03B
$152 ﹤0.01%
+7
New +$146
FC icon
3006
Franklin Covey
FC
$246M
$152 ﹤0.01%
4
ASTS icon
3007
AST SpaceMobile
ASTS
$21.5B
$151 ﹤0.01%
+13
New +$68
KOS icon
3008
Kosmos Energy
KOS
$1.48B
$150 ﹤0.01%
27
VRDN icon
3009
Viridian Therapeutics
VRDN
$2.67B
$143 ﹤0.01%
11
-95
-90% -$1.31K
FCEL icon
3010
FuelCell Energy
FCEL
$1.63B
$141 ﹤0.01%
7
-29
-81% -$778
EVBG
3011
DELISTED
Everbridge, Inc. Common Stock
EVBG
$140 ﹤0.01%
4
NXDT
3012
NexPoint Diversified Real Estate Trust
NXDT
$238M
$138 ﹤0.01%
+25
New +$143
NATR icon
3013
Nature's Sunshine
NATR
$288M
$136 ﹤0.01%
9
-27
-75% -$461
JBIO
3014
Jade Biosciences
JBIO
$1.34B
$133 ﹤0.01%
2
-1
-33% -$663
BTE icon
3015
Baytex Energy
BTE
$2.92B
$129 ﹤0.01%
37
RBOT
3016
DELISTED
Vicarious Surgical
RBOT
$129 ﹤0.01%
+22
New +$197
EVEX icon
3017
Eve Holding
EVEX
$962M
$126 ﹤0.01%
+31
New +$156
GEF.B icon
3018
Greif Class B
GEF.B
$4.21B
$125 ﹤0.01%
2
GIC icon
3019
Global Industrial
GIC
$1.49B
$125 ﹤0.01%
+4
New +$147
BLRX
3020
BioLineRX
BLRX
$11.8M
$124 ﹤0.01%
5
-95
-95% -$2.55K
ECF
3021
Ellsworth Growth & Income Fund
ECF
$172M
$124 ﹤0.01%
15
BBBY
3022
Bed Bath & Beyond
BBBY
$442M
$118 ﹤0.01%
10
+2
+25% +$36
INZY
3023
DELISTED
Inozyme Pharma
INZY
$107 ﹤0.01%
24
-24
-50% -$116
NBP
3024
NovaBridge Biosciences American Depositary Shares
NBP
$202M
$105 ﹤0.01%
63
NAUT icon
3025
Nautilus Biotechnolgy
NAUT
$115M
$103 ﹤0.01%
44
-61
-58% -$159

Similar funds

GAMMA Investing's Q2 2024 Portfolio in Review

As of Q2 2024, GAMMA Investing held 3,583 positions worth $734M, up 49% from $491M the previous quarter. Its ten largest holdings account for 26% of the portfolio.

GAMMA Investing deployed $225M of net new capital in Q2 2024, opening 262 new positions and adding to 2,226 existing holdings. Its largest new stake was GE Vernova: 4,526 shares worth $776K.

By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 22% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was PIMCO Intermediate Municipal Bond Active Exchange-Traded Fund, an estimated $373K trimmed.

  • GAMMA Investing's largest Q2 2024 buy was GE Vernova: 4,526 shares worth $776K.
  • GAMMA Investing added most to Apple in Q2 2024, an estimated $11.8M increase.
  • GAMMA Investing's biggest Q2 2024 reduction was PIMCO Intermediate Municipal Bond Active Exchange-Traded Fund, cutting an estimated $373K.
  • GAMMA Investing fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $383K.
  • GAMMA Investing's ten largest holdings make up 26% of its $734M portfolio in Q2 2024.
  • GAMMA Investing opened 262 new positions and closed 123 in Q2 2024.
  • GAMMA Investing's portfolio value rose 49% quarter-over-quarter to $734M.

Based on GAMMA Investing's 13F filing for Q2 2024, filed 2 Jul 2024.